Use of OCT Angiography to Diagnose and Manage Atypical Presentations of Macular Telangiectasia Type 2.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
16 Jul 2022
Historique:
received: 24 05 2022
revised: 13 07 2022
accepted: 14 07 2022
entrez: 27 7 2022
pubmed: 28 7 2022
medline: 29 7 2022
Statut: epublish

Résumé

Macular telangiectasia Type 2 (MacTel) is a bilateral acquired retinal disease characterized by both vascular changes and atrophy of the retina. The purpose of this case series is to highlight the use of optical coherence tomography angiography (OCTA) as a non-invasive imaging modality to distinguish atypical MacTel from other macular conditions with similar presentations. We performed a retrospective review of patients referred to our academic retinal practice with unconfirmed or misdiagnosed MacTel between July 2017 and July 2021. Patients' OCTA imaging findings were reviewed to guide the appropriate diagnosis and management of atypical MacTel. Fifteen eyes from eight patients were included in this study. Six patients were referred with previous diagnoses of either full-thickness macular hole, lamellar hole, vitreomacular traction (VMT), postoperative cystoid macular edema (CME), or diabetic macular edema (DME). Two patients were referred to us to confirm the diagnosis of MacTel. OCTA revealed telangiectatic vessels in the temporal parafovea of all 15 eyes. OCTA also highlighted previously undiagnosed subretinal neovascularization (SRNV) in seven eyes. OCTA imaging is a valuable imaging modality to distinguish MacTel from other macular conditions, whose treatment courses vary substantially. Due to its ease of use, it holds immense potential in the future as treatments for non-proliferative MacTel emerge.

Identifiants

pubmed: 35887197
pii: ijms23147849
doi: 10.3390/ijms23147849
pmc: PMC9321649
pii:
doi:

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Références

Graefes Arch Clin Exp Ophthalmol. 2021 May;259(5):1135-1143
pubmed: 33201355
Retin Cases Brief Rep. 2021 Jul 1;15(4):369-372
pubmed: 30096103
Ophthalmology. 2010 Dec;117(12):2407-16
pubmed: 20678804
Br J Ophthalmol. 2016 Nov;100(11):1482-1488
pubmed: 26823394
J Ophthalmol. 2011;2011:928205
pubmed: 21811669
JAMA Ophthalmol. 2015 Aug;133(8):951-4
pubmed: 26067680
Br J Ophthalmol. 2021 Sep;105(9):1289-1296
pubmed: 30808615
Curr Diab Rep. 2019 Jul 29;19(9):68
pubmed: 31359157
Int J Retina Vitreous. 2020 Nov 13;6(1):55
pubmed: 33292740
Int Ophthalmol. 2019 Oct;39(10):2245-2256
pubmed: 30607862
Retina. 2014 May;34(5):907-15
pubmed: 24270919
Turk J Ophthalmol. 2017 Oct;47(5):279-284
pubmed: 29109897
Retina. 2014 May;34(5):916-9
pubmed: 24351446
Ophthalmol Retina. 2020 May;4(5):494-497
pubmed: 32063517
Eye (Lond). 2009 Feb;23(2):435-41
pubmed: 18259211
Retina. 2018 Jan;38 Suppl 1:S8-S13
pubmed: 28505012
Medicine (Baltimore). 2021 Sep 10;100(36):e27078
pubmed: 34516496
Retina. 2010 Mar;30(3):473-8
pubmed: 19952995
Am J Ophthalmol. 2015 Apr;159(4):659-666.e1
pubmed: 25528956
Br J Ophthalmol. 2021 May;105(5):735-740
pubmed: 32513667
Ophthalmol Retina. 2021 Jul;5(7):711-713
pubmed: 33338669
Case Rep Ophthalmol Med. 2020 Dec 07;2020:8884638
pubmed: 33489395
Invest Ophthalmol Vis Sci. 2016 Jul 1;57(9):OCT268-76
pubmed: 27409482
Retina. 2016 Mar;36(3):524-34
pubmed: 26618805
Ophthalmology. 1993 Oct;100(10):1536-46
pubmed: 8414413
Invest Ophthalmol Vis Sci. 2017 Jul 1;58(9):3683-3689
pubmed: 28727884
Ophthalmic Surg Lasers Imaging Retina. 2015 Sep;46(8):883-6
pubmed: 26431306
PLoS One. 2020 Apr 29;15(4):e0232255
pubmed: 32348375
Am J Ophthalmol. 2021 Aug;228:27-34
pubmed: 33775659
JAMA Ophthalmol. 2015 Jan;133(1):66-73
pubmed: 25317692
Sci Rep. 2020 Oct 6;10(1):16594
pubmed: 33024250
Ophthalmology. 2019 Apr;126(4):540-549
pubmed: 30292541
Retina. 2016 Nov;36(11):2150-2157
pubmed: 27258671
Retina. 2010 Feb;30(2):317-26
pubmed: 19881399
Am J Ophthalmol. 2010 Jul;150(1):55-62.e2
pubmed: 20609708
Indian J Ophthalmol. 2015 May;63(5):394-8
pubmed: 26139799
Prog Retin Eye Res. 2013 May;34:49-77
pubmed: 23219692

Auteurs

John Moir (J)

Pritzker School of Medicine, University of Chicago, Chicago, IL 60637, USA.
Department of Ophthalmology and Visual Science, University of Chicago Medical Center, Chicago, IL 60637, USA.

Shivam V Amin (SV)

Department of Ophthalmology and Visual Science, University of Chicago Medical Center, Chicago, IL 60637, USA.

Saira Khanna (S)

Department of Ophthalmology and Visual Science, University of Chicago Medical Center, Chicago, IL 60637, USA.

Rahul Komati (R)

Department of Ophthalmology and Visual Science, University of Chicago Medical Center, Chicago, IL 60637, USA.
Georgia Retina, Stockbridge, GA 30281, USA.

Lincoln T Shaw (LT)

Department of Ophthalmology and Visual Science, University of Chicago Medical Center, Chicago, IL 60637, USA.

David Dao (D)

Department of Ophthalmology and Visual Science, University of Chicago Medical Center, Chicago, IL 60637, USA.

Seenu M Hariprasad (SM)

Department of Ophthalmology and Visual Science, University of Chicago Medical Center, Chicago, IL 60637, USA.

Dimitra Skondra (D)

Department of Ophthalmology and Visual Science, University of Chicago Medical Center, Chicago, IL 60637, USA.
J. Terry Ernest Ocular Imaging Center, University of Chicago Medical Center, Chicago, IL 60637, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH